Graves Ophthalmopathy – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Graves ophthalmopathy (also known as Graves’ eye disease, Graves’ ophthalmopathy, Graves’ orbitopathy, TED) is an autoimmune inflammatory process that affects the orbital and periorbital tissue, closely associated with dysthyroidism. Etiology- Thyroid eye disease is an autoimmune disorder. Usually caused by Graves’ disease, but it can also be associated with Hashimoto's thyroiditis. Epidemiology- It is estimated to be 16 per 100,000 women in the general population, and 2.9 per 100,000 men in the general population. The competitive landscape of Graves Ophthalmopathy includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Graves Ophthalmopathy across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landsc...